Design and Synthesis of Sulfur Based Inhibitors of Matrix Metalloproteinase-1
スポンサーリンク
概要
- 論文の詳細を見る
Fibroblast collagenase(MMP-1), a member of the matrix metalloproteinases family, is believed to be a pathogenesis of arthritis, by cleaving triple-helical type II collagen in cartilage. From the similarity of the active site zinc binding mode with hydroxamate, we designed and synthesized α-mercaptocarbonyl possessing compounds(3-5), which incorporated various peptide sequences as enzyme recognition sites. The P_4P_1 peptide incorporating compound(3)exhibited as potent inhibition as the hydroxamate(1)and the carboxylate(2)type inhibitors, with an IC_<50> of 10^<-6>M order against MMP-1. But the inhibitor(3)related compounds(6-8)displayed decreased or no inihibitory potencies. These results suggest that the existence of both the carbonyl and thiol group might be critical for the inihibition, and the distance between the two functional groups is important for inhibitory potency. For P_n' peptide incorporating compounds(4a-k), except for 4h and 4k, all compounds shoed IC_<50> values under sub-nanomolar. Among them, for potent inhibition, Leu was better than Phe and Val as the P_1' amino acid, and the P_2' position amino acid was necessary, and preferentially Phe. Insertion of the P peptide into 4d or 4k, giving compounds 5a-c, did not increase the activities of 4d and 4k. Substitution of the mercapto group with other functional groups lost the activity of compound 4a. The stereochemical preference at the thiol-attached position was also determined by preparation of both isomers of 4a. It was found that the S configuration compound(36b)is approximately 100 times more potent than the corresponding R-isomer(36a).
- 社団法人日本薬学会の論文
- 2002-02-01
著者
-
Ogawa Y
Research Institute Daiichi Fine Chemical Co. Ltd.
-
FUJISAWA Tetsunori
Research Institute, Daiichi Fine Chemical Co., Ltd.
-
ODAKE Shinjiro
Research Institute, Daiichi Fine Chemical Co., Ltd.
-
OGAWA Yuji
Research Institute, Daiichi Fine Chemical Co., Ltd.
-
YASUDA Junko
Research Institute, Daiichi Fine Chemical Co., Ltd.
-
MORIKAWA Tadanori
Research Institute, Daiichi Fine Chemical Co., Ltd.
-
MORITA Yasuo
Research Institute, Fuji Chemical Industries, Ltd.
-
Morita Yasuo
Research Institute Fuji Chemical Industries Ltd.
-
Yasuda Junko
Research Institute Daiichi Fine Chemical Co. Ltd.
-
Odake S
Research Institute Daiichi Fine Chemical Co. Ltd.
-
Morikawa Tadanori
Research Institute Daiichi Fine Chemical Co. Ltd.
-
Fujisawa Tetsunori
Research Institute Daiichi Fine Chemical Co. Ltd.
-
Odake Shinjiro
Research Institute Daiichi Fine Chemical Co. Ltd.
関連論文
- Sulfur Based Inhibitors of Matrix Metalloproteinase-1
- Design and Synthesis of Sulfur Based Inhibitors of Matrix Metalloproteinase-1
- Exploration of Orally-Available and Long-Acting Opioid peptides
- Synthesis and Antinociceptive Activity of Orally Active Opioid Peptides: Improvement of Oral Bioavailability by Esterification
- Structure-Activity Relationships (SAR) of [D-Arg^2] Dermorphin(1-4) Analogues, N^α-Amidino-Tyr-D-Arg-phe-X
- Synthesis and in vivo Structure-Activity Relationships (SAR) of Orally-Active Analgesic Peptide, N^α-Amidino-Tyr-D-Arg-Phe-MeβAla-OH (ADAMB)
- Synthesis of Lactam-Conformationally Restricted Arg-AA Dipeptide Isostere
- INHIBITION OF CORNEAL ULCERATION BY TETRAPEPTIDYL HYDROXAMIC ACID
- Anticoagulant Peptides; Synthesis, Stability and Antithrombin Activity of Hirudin C-Terminal-Related Peptides and Their Disulfated Analog
- Antithrombotic Effects of Thrombin Anion-Binding Exosite Inhibitors
- Synthesis and Anticoagulant Activities of Disulfated Hirudin C-Terminal Related Peptides
- Design and Synthesis of Carboxylate Inhibitors for Matrix Metalloproteinases
- Non-hydroxamate Peptidyl Inhibitors of Matrix Metalloproteinases
- Reducing Effect of Matrix Metalloproteinase Inhibitors on Serum Triacylglycerol in Streptozotocin-Induced Diabetic Rats and Zucker fa/fa Rats(Pharmacology)